Status:

RECRUITING

Health Improvements by Understanding the Determinants of Residual Risk in Coronary Artery Disease and New Targets for Prevention and Treatment

Lead Sponsor:

Fondazione Toscana Gabriele Monasterio

Collaborating Sponsors:

CNR Institute of Clinical Physiology, Pisa, Italy

IRCCS SYNLAB SDN, Naples, Italy

Conditions:

Coronary Arterial Disease (CAD)

Eligibility:

All Genders

40-75 years

Brief Summary

Current medical treatments, in patients with stable coronary artery disease (CAD), mainly target established risk factors and are able to reduce morbidity and mortality but still leave a substantial r...

Detailed Description

HURRICANE is an observational clinical study, performed in retrospective and prospective cohorts of patients with stable CAD, to assess the role of emerging cardiometabolic and vascular risk determina...

Eligibility Criteria

Inclusion

  • RETROSPECTIVE STUDY
  • patients with known or suspected stable CAD who underwent CCT for the registered studies "SMARTool" or "Studio di biomarcatori in vivo ed in vitro"
  • fully accessible CCT image files and whole blood and plasma/serum aliquots stored in BioBank
  • written informed consent

Exclusion

  • overt heart failure (NYHA Class III-IV) and/or reduced systolic LV function (LVEF\<40%)
  • relevant comorbid conditions limiting expected survival to less than 1 year
  • CCT exam of suboptimal quality
  • PROSPECTIVE STUDY
  • Inclusion Criteria:
  • patients with suspected stable CAD clinically referred for a first diagnostic CCT
  • fully accessible CCT image files and whole blood and plasma/serum aliquots stored in BioBank
  • written informed consent

Key Trial Info

Start Date :

July 7 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

961 Patients enrolled

Trial Details

Trial ID

NCT06601153

Start Date

July 7 2023

End Date

December 1 2025

Last Update

September 19 2024

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Fondazione Toscana Gabriele Monasterio

Pisa, Italy, Italy, 56124

2

Irccs Synlab Sdn

Napoli, Italy, 80121

Health Improvements by Understanding the Determinants of Residual Risk in Coronary Artery Disease and New Targets for Prevention and Treatment | DecenTrialz